Keith Brew
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Keith Brew has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- K. Ravi Acharya
Department of Life Sciences University of Bath UK
6 shared publications Percy Tumbale
Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Boca Raton, FL 33431, USA
3 shared publicationsShuo Wei
3 shared publicationsBrittany Stinson
Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida 33431
2 shared publicationsHarinath Bahudhanapati
Department of Basic Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida 33431, USA
2 shared publicationsMichelle Lizotte-Waniewski
Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida 33431
2 shared publications
Latest Publications
- Open Access
- 1 May 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (21) , 11348-11358
Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14
- 1 May 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (21) , 11348-11358
Open AccessThermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14
- Open Access
- 1 March 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (12) , 8041-8050
Structures of Complexes of a Metal-independent Glycosyltransferase GT6 from Bacteroides ovatus with UDP-N-Acetylgalactosamine (UDP-GalNAc) and Its Hydrolysis Products
- 1 March 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (12) , 8041-8050
Open AccessStructures of Complexes of a Metal-independent Glycosyltransferase GT6 from Bacteroides ovatus with UDP-N-Acetylgalactosamine (UDP-GalNAc) and Its Hydrolysis Products
- Open Access
- 7 December 2012
- Published by Springer Nature in Scientific Reports
- Vol. 2 (1) , srep00940
Structure of a metal-independent bacterial glycosyltransferase that catalyzes the synthesis of histo-blood group A antigen
Histo-blood group antigens (HBGAs) are a source of antigenic variation between individuals that modulates resistance and susceptibility to pathogens and is a barrier to the spread of enveloped viruses. HBGAs are also produced by a few prokaryotes where they are synthesized by glycosyltransferases (GTs) related to human HBGA synthases. Here we report the first structure of a bacterial GT of this family, from an intestinal resident, Bacteroides ovatus. Unlike its mammalian homologues and other GTs with similar folds, this protein lacks a metal-binding Asp-X-Asp motif and is fully active in the absence of divalent metal ions, yet is strikingly similar in structure and in its interactions with substrates to structurally characterized mammalian metal-dependent mammalian homologues. This shows how an apparently major divergence in catalytic properties can be accommodated by minor structural adjustments and illustrates the structural underpinnings of horizontal transfer of a functional gene from prokaryotes to vertebrates.
- 7 December 2012
- Published by Springer Nature in Scientific Reports
- Vol. 2 (1) , srep00940
Open AccessStructure of a metal-independent bacterial glycosyltransferase that catalyzes the synthesis of histo-blood group A antigen
Histo-blood group antigens (HBGAs) are a source of antigenic variation between individuals that modulates resistance and susceptibility to pathogens and is a barrier to the spread of enveloped viruses. HBGAs are also produced by a few prokaryotes where they are synthesized by glycosyltransferases (GTs) related to human HBGA synthases. Here we report the first structure of a bacterial GT of this family, from an intestinal resident, Bacteroides ovatus. Unlike its mammalian homologues and other GTs with similar folds, this protein lacks a metal-binding Asp-X-Asp motif and is fully active in the absence of divalent metal ions, yet is strikingly similar in structure and in its interactions with substrates to structurally characterized mammalian metal-dependent mammalian homologues. This shows how an apparently major divergence in catalytic properties can be accommodated by minor structural adjustments and illustrates the structural underpinnings of horizontal transfer of a functional gene from prokaryotes to vertebrates.
- Open Access
- 28 June 2012
- Published by Springer Nature in Cell Death & Disease
- Vol. 3 (6) , e332
Tissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: mechanisms and relevance to HIV-1-associated dementia
HIV-1-associated dementia (HAD)-relevant proinflammatory cytokines robustly induce astrocyte tissue inhibitor of metalloproteinases-1 (TIMP-1). As TIMP-1 displays pleotropic functions, we hypothesized that TIMP-1 expression may serve as a neuroprotective response of astrocytes. Previously, we reported that chronically activated astrocytes fail to maintain elevated TIMP-1 expression, and TIMP-1 levels are lower in the brain of HAD patients; a phenomenon that may contribute to central nervous system pathogenesis. Further, the role of TIMP-1 as a neurotrophic factor is incompletely understood. In this study, we report that staurosporine (STS) and HIV-1ADA virus, both led to induction of apoptosis in cultured primary human neurons. Interestingly, cotreatment with TIMP-1 protects neurons from apoptosis and reverses neuronal morphological changes induced by these toxins. Further, the anti-apoptotic effect was not observed with TIMP-2 or -3, but was retained in a mutant of the N-terminal TIMP-1 protein with threonine-2 mutated to glycine (T2G) that is deficient in matrix metalloproteinase (MMP)-1, -2 and -3 inhibitory activity. Therefore, the mechanism is specific to TIMP-1 and partially independent of MMP-inhibition. Additionally, TIMP-1 modulates the Bcl-2 family of proteins and inhibits opening of mitochondrial permeability transition pores induced by HIV-1 or STS. Together, these findings describe a novel function, mechanism and direct role of TIMP-1 in neuroprotection, suggesting its therapeutic potential in HAD and possibly in other neurodegenerative diseases.
- 28 June 2012
- Published by Springer Nature in Cell Death & Disease
- Vol. 3 (6) , e332
Open AccessTissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: mechanisms and relevance to HIV-1-associated dementia
HIV-1-associated dementia (HAD)-relevant proinflammatory cytokines robustly induce astrocyte tissue inhibitor of metalloproteinases-1 (TIMP-1). As TIMP-1 displays pleotropic functions, we hypothesized that TIMP-1 expression may serve as a neuroprotective response of astrocytes. Previously, we reported that chronically activated astrocytes fail to maintain elevated TIMP-1 expression, and TIMP-1 levels are lower in the brain of HAD patients; a phenomenon that may contribute to central nervous system pathogenesis. Further, the role of TIMP-1 as a neurotrophic factor is incompletely understood. In this study, we report that staurosporine (STS) and HIV-1ADA virus, both led to induction of apoptosis in cultured primary human neurons. Interestingly, cotreatment with TIMP-1 protects neurons from apoptosis and reverses neuronal morphological changes induced by these toxins. Further, the anti-apoptotic effect was not observed with TIMP-2 or -3, but was retained in a mutant of the N-terminal TIMP-1 protein with threonine-2 mutated to glycine (T2G) that is deficient in matrix metalloproteinase (MMP)-1, -2 and -3 inhibitory activity. Therefore, the mechanism is specific to TIMP-1 and partially independent of MMP-inhibition. Additionally, TIMP-1 modulates the Bcl-2 family of proteins and inhibits opening of mitochondrial permeability transition pores induced by HIV-1 or STS. Together, these findings describe a novel function, mechanism and direct role of TIMP-1 in neuroprotection, suggesting its therapeutic potential in HAD and possibly in other neurodegenerative diseases.
- Open Access
- 1 September 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (36) , 31761-31770
Phage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2)
- 1 September 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (36) , 31761-31770
Open AccessPhage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2)
- Open Access
- 1 May 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (19) , 16891-16899
Entropy Increases from Different Sources Support the High-affinity Binding of the N-terminal Inhibitory Domains of Tissue Inhibitors of Metalloproteinases to the Catalytic Domains of Matrix Metalloproteinases-1 and -3
- 1 May 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (19) , 16891-16899
Open AccessEntropy Increases from Different Sources Support the High-affinity Binding of the N-terminal Inhibitory Domains of Tissue Inhibitors of Metalloproteinases to the Catalytic Domains of Matrix Metalloproteinases-1 and -3
- Open Access
- 1 September 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (37) , 25126-25134
Characterization of a Metal-independent CAZy Family 6 Glycosyltransferase from Bacteroides ovatus
- 1 September 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (37) , 25126-25134
Open AccessCharacterization of a Metal-independent CAZy Family 6 Glycosyltransferase from Bacteroides ovatus
- 18 April 2008
- Published by Elsevier in Journal of Molecular Biology
- Vol. 378 (1) , 295-296
Corrigendum to “Conformational Changes Induced by Binding of UDP–2F-galactose to α-1,3 Galactosyltransferase—Implications for Catalysis” [J. Mol. Biol. 369 (2007) 1270–1281]
- 18 April 2008
- Published by Elsevier in Journal of Molecular Biology
- Vol. 378 (1) , 295-296
Corrigendum to “Conformational Changes Induced by Binding of UDP–2F-galactose to α-1,3 Galactosyltransferase—Implications for Catalysis” [J. Mol. Biol. 369 (2007) 1270–1281]
- 1 September 2007
- Published by Wiley in Protein Science
- Vol. 16 (9) , 1905-1913
Constraining specificity in the N‐domain of tissue inhibitor of metalloproteinases‐1; gelatinase‐selective inhibitors
The tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors of the matrix metalloproteinases (MMPs). Since unregulated MMP activities are linked to arthritis, cancer, and atherosclerosis, TIMP variants that are selective inhibitors of disease‐related MMPs have potential therapeutic value. The structures of TIMP/MMP complexes reveal that most interactions with the MMP involve the N‐terminal pentapeptide of TIMP and the C–D β‐strand connector which occupy the primed and unprimed regions of the active site. The loop between β‐strands A and B forms a secondary interaction site for some MMPs, ranging from multiple contacts in the TIMP‐2/membrane type‐1 (MT1)‐MMP complex to none in the TIMP‐1/MMP‐1 complex. TIMP‐1 and its inhibitory domain, N‐TIMP‐1, are weak inhibitors of MT1‐MMP; inhibition is not improved by grafting the longer AB loop from TIMP‐2 into N‐TIMP‐1, but this change impairs binding to MMP‐3 and MMP‐7. Mutational studies with N‐TIMP‐1 suggest that its weak inhibition of MT1‐MMP, as compared to other N‐TIMPs, arises from multiple (>3) sequence differences in the interaction site. Substitutions for Thr2 of N‐TIMP‐1 strongly influence MMP selectivity; Arg and Gly, that generally reduce MMP affinity, have less effect on binding to MMP‐9. When the Arg mutation is added to the N‐TIMP‐1(AB2) mutant, it produces a gelatinase‐specific inhibitor with Ki values of 2.8 and 0.4 nM for MMP‐2 and ‐9, respectively. Interestingly, the Gly mutant has a Ki of 2.1 nM for MMP‐9 and >40 μM for MMP‐2, indicating that engineered TIMPs can discriminate between MMPs in the same subfamily.
- 1 September 2007
- Published by Wiley in Protein Science
- Vol. 16 (9) , 1905-1913
Constraining specificity in the N‐domain of tissue inhibitor of metalloproteinases‐1; gelatinase‐selective inhibitors
The tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors of the matrix metalloproteinases (MMPs). Since unregulated MMP activities are linked to arthritis, cancer, and atherosclerosis, TIMP variants that are selective inhibitors of disease‐related MMPs have potential therapeutic value. The structures of TIMP/MMP complexes reveal that most interactions with the MMP involve the N‐terminal pentapeptide of TIMP and the C–D β‐strand connector which occupy the primed and unprimed regions of the active site. The loop between β‐strands A and B forms a secondary interaction site for some MMPs, ranging from multiple contacts in the TIMP‐2/membrane type‐1 (MT1)‐MMP complex to none in the TIMP‐1/MMP‐1 complex. TIMP‐1 and its inhibitory domain, N‐TIMP‐1, are weak inhibitors of MT1‐MMP; inhibition is not improved by grafting the longer AB loop from TIMP‐2 into N‐TIMP‐1, but this change impairs binding to MMP‐3 and MMP‐7. Mutational studies with N‐TIMP‐1 suggest that its weak inhibition of MT1‐MMP, as compared to other N‐TIMPs, arises from multiple (>3) sequence differences in the interaction site. Substitutions for Thr2 of N‐TIMP‐1 strongly influence MMP selectivity; Arg and Gly, that generally reduce MMP affinity, have less effect on binding to MMP‐9. When the Arg mutation is added to the N‐TIMP‐1(AB2) mutant, it produces a gelatinase‐specific inhibitor with Ki values of 2.8 and 0.4 nM for MMP‐2 and ‐9, respectively. Interestingly, the Gly mutant has a Ki of 2.1 nM for MMP‐9 and >40 μM for MMP‐2, indicating that engineered TIMPs can discriminate between MMPs in the same subfamily.